Published March 29, 2018
Transfection is a procedure used for the introduction of nucleic acids into eukaryotic cells. Nucleic acids are also referred to as small biomolecules or biopolymers. There are different terms of transfection like in animal cells; the transfection term is referred as the transformation used to describe the non-animal eukaryotic cells and progression to carcinogenesis in the animal cells. In this process, the double-stranded DNA and RNA are genetic materials introduced into mammalian cells by non-viral transformation. In the process of DNA introduction into cells, by using their machinery, it will produce proteins. When RNA is transfected, RNA is used to regulate protein expression by blocking translation and act as a cytoplasm.
The Middle East and Africa Transfection Technologies Market Size& Growth:
The Middle East and Africa transfection technologies market size is envisaged to project XX Billion by the end of 2024 with a CAGR of close to XX% from XX Billion in 2018 during the forecast period 2018-2024. The key attributes promoting the Middle East and Africa transfection technologies market are increasing the prevalence of cancer and infectious diseases, rising demand for protein production, government initiatives, and top players investments, and rise in R&D in the field of cell-based therapies. Expensive transfection technology instruments and the risks regarding the cells with adverse reactions are the major restraints influencing the market growth. The technological advancements and growing applications in stem cell therapy, and gene therapy are creating significant growth opportunities to the Middle East and Africa transfection technologies market growth. Generally, there is a need for technologies to address the transfection in hard-to-transfect cells. This type of requirement of disruptive technologies for this approach is considered as the challenges of the market. Transfection technologies are getting the popularity worldwide due to the manufacturers, and the top players are coming up with innovative instruments which are less complicated and easy to use.
The Middle East and Africa Transfection Technologies Market Segments Share:
The Middle East and Africa transfection technologies market are categorised into segments by the method, by application, by end-users, and by geography. The methods segment is again classified into instrument-based methods, reagent-based methods, and virus-based methods. By instrument-based methods, the market is classified into electroporation, microinjection, Laserfection, biolistic technology. Electroporation instruments are majorly used in the microbiology applications, and these electroporation instruments are driving the market growth during the forecast period, owing to the rise in awareness level of healthcare, and new product launches. By application, the market is segmented into biomedical research, cancer research, transgenic models, gene and protein expression studies, and others. Bio-medical research and methods hold the largest share due to its cost advantage and simplicity. By end-users, the market is segmented into hospitals, clinics, pharmaceutical and biotechnology companies, and others. By geography, the market is partitioned into North America, Asia Pacific, Europe, the Middle East and Africa, and South America.
The Middle East and Africa Transfection Technologies Market Trends:
The Middle East and Africa Transfection Technologies Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The major key players in the Middle East and Africa Transfection Technologies Market are:
Along with these companies, there were many other companies considered/ cited in the report while analysing the Middle East and Africa transfection technologies market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1.1. Increasing prevalence of cancer and infectious diseases
4.1.2. Rising demand for protein production
4.1.3. Advent of the biopharmaceutical market
4.1.4. Rise in R&D in the field of cell-based therapies
4.1.5. Government and top player’s investments
4.2.1. Expensive transfection technology instruments
4.2.2. High risk with the cells of adverse reactions
4.3.1. Advancements in Stem cell therapy, and Gene therapy
4.4.1. Need of disruptive technologies to address transfection in hard-to-transfect cells
5. Middle East and Africa Transfection Technologies Market– By Method
5.1. Instrument-Based Methods
5.1.4. Biolistic Technology
5.2. Reagent-Based Methods
5.2.1. Lipofection (Lipid Mediated Transfection)
5.2.2. Calcium Phosphate
5.2.3. Cationic Polymers
5.2.4. Activated Dendrimers
5.2.5. DEAE dextran
5.2.6. Magnetic Beads (Magnet-mediated Transfection)
5.3. Virus-Based Methods
6. Middle East and Africa Transfection Technologies Market– By Application
6.1. Bio-Medical Research
6.2. Cancer Research
6.3. Transgenic Models
6.4. Gene and Protein Expression Studies
6.5. Therapeutic Delivery
6.5.2. Electro-chemotherapy and Electro-immunotherapy
6.6. Protein Production
6.7. Cell-Based Microarray for Drug Discovery and Development
7. Middle East and Africa Transfection Technologies Market- By End-users
7.3. Pharmaceutical & Biotechnology Companies
8. Middle East and Africa Transfection Technologies Market– By Geography
8.2. Middle East & Africa
8.2.1. Middle East
9. Middle East and Africa Transfection Technologies Market– Company Profiles
9.1. Bio-Rad Laboratories Inc.
9.2. Polyplus Transfection
9.3. Promega Corporation
9.4. Thermo Fisher Scientific
9.5. Lonza Group
9.6. MaxCyte Inc.
9.7. Agilent Technologies
9.9. Boca Scientific Inc.
9.10. Roche Holding AG
9.11. Altogen Biosystems
9.13. SignaGen Laboratories
9.14. Promo Cell GmbH
10. Middle East and Africa Transfection Technologies Market- Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12.1. List of tables
12.2. List of figures